The Official Newsletter ofCentinel Spine®

Jan. 31st, 2025

NOW AVAILABLE: prodisc® C Vivo / prodisc® C SK U.S. Competitive Comparison versus Mobi-C®

Ashlyn Miller
By Ashlyn Miller
Associate Product Director, Motion

The Competitive Comparison can be found on the Mobile Hub.

Centinel Spine recently released a comprehensive competitive comparison of prodisc C Vivo and prodisc C SK vs Mobi-C.

This document was designed to guide a competitive conversation between you and your customers. It offers valuable insights into the clinical history, surgical techniques, and device overviews of the products. Please take some time to review this comparison—it will serve as a useful tool in identifying strengths and areas of opportunity in comparison to Mobi-C.

The Competitive Comparison can be found on the Mobile Hub for U.S. users by navigating to:

  • Product Solutions > prodisc C Vivo > prodisc C Vivo (US) > Competitive Intel > Competitive Comparison: prodisc C Vivo & SK vs Mobi-C
  • Product Solutions > prodisc C SK > Competitive Intel > Competitive Comparison: prodisc C Vivo & SK vs Mobi-C


To download a PDF of the comparison, click the button below.
 

M
M

If you have further questions, contact:

Ashlyn Miller
Associate Product Director, Motion
More From Centinel Spine:
The Big Story
Centinel Spine Receives 2-Level FDA Approval for prodisc® C Vivo & prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices
Read On
The Big Story
Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
Read On
Centinel Spine® Receives MDR Certification for prodisc® C Vivo & prodisc® C Nova Cervical Total Disc Replacement Systems
Read On
Centinel Spine in the News: Centinel Spine's prodisc® Revolution—Redefining Motion Preservation in 2025
Read On
Q3 2025 Medical Education Event Recap
Read On
WATCH:
Centinel Spine - CSRS Cadaveric Surgical Technique Video Featuring prodisc® C Vivo
Read On
New Surgeon Blog Post Educates on Non-Surgical Ways to Relieve Neck Pain
Read On